[Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)]

A Le Querrec; A Derlon; J P Deshayes; C Lefrançois; B Sillard; P Delassus; J F Viel; A Kher; M Thomas

[Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)]

J Mal Vasc. 1987:12 Suppl B:99-101.

[Article in French]

Authors

A Le Querrec¹, A Derlon, J P Deshayes, C Lefrançois, B Sillard, P Delassus, J F Viel, A Kher, M Thomas

Affiliation

¹ Département d'Anesthésiologie, C.H.U. Côte de Nacre, Caen.

PMID: 2834502

Abstract

Efficacy of a low molecular weight heparin (Kabi 2165) was compared with that of non-fractionated heparin in the prevention of abdominal surgery postoperative venous thrombosis by means of a double-blind randomized trial in 79 patients. Determination of D. dimers in these patients allowed assessment of specificity of this assay for detection of postoperative venous thrombosis.

Publication types

Clinical Trial
Comparative Study
English Abstract
Randomized Controlled Trial

MeSH terms

Abdomen / surgery
Blood Coagulation Tests
Double-Blind Method
Drug Evaluation
Factor X / analysis
Fibrin Fibrinogen Degradation Products / analysis
Heparin / therapeutic use*
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Postoperative Complications / prevention & control*
Random Allocation
Thromboembolism / prevention & control*

Substances

Fibrin Fibrinogen Degradation Products
Heparin, Low-Molecular-Weight
Factor X
Heparin